<- Go Home
PolyNovo Limited
PolyNovo Limited designs, manufactures, and sells biodegradable medical devices in Australia, New Zealand, the United States, the United Kingdom, Ireland, Singapore, India, Hong Kong, and China. The company offers NovoSorb Biodegradable Temporising Matrix, a dermal matrix for the regeneration of the dermis when lost through extensive surgery, trauma, or burn; NovoSorb MTX for burns, chronic, trauma, and surgical wounds; and hernia repair, plastics and reconstructive device products. The company was formerly known as Calzada Limited and changed its name to PolyNovo Limited in November 2014. PolyNovo Limited was incorporated in 1998 and is headquartered in Port Melbourne, Australia.
Market Cap
AUD 663.2M
Volume
2.6M
Cash and Equivalents
AUD 35.4M
EBITDA
AUD 15.5M
Tax Rate Collected
N/A
Tax Rate Ratio
N/A
Gross Profit
AUD 129.3M
Profit Margin
86.28%
52 Week High
AUD 1.66
52 Week Low
AUD 0.81
Dividend
N/A
Price / Book Value
7.31
Price / Earnings
91.43
Price / Tangible Book Value
7.35
Enterprise Value
AUD 645.3M
Enterprise Value / EBITDA
38.47
Operating Income
AUD 13.3M
Return on Equity
8.44%
Return on Assets
6.42
Cash and Short Term Investments
AUD 35.5M
Debt
AUD 17.6M
Equity
AUD 90.7M
Revenue
AUD 149.8M
Unlevered FCF
-AUD 1.2M
Sector
Health Care Equipment and Supplies
Category
N/A